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Abstract
BACKGROUND: Oroantral fistula (OAF) is a pathological communication between maxillary sinus and oral cavity, 
which treated by various surgical methods including buccal flap and associated with post-operative discomfort and 
relatively long healing period.
AIM: The objective of the study was to evaluate the effect of 0.2% hyaluronic acid (HA) gel on the healing period after 
surgical buccal flap treatment of OAF.
METHODS: The records of 20 patients of both genders included and reviewed retrospectively. Ten patients treated 
with topical 0.2% HA gel while the other 10 patients treated without it. Patients healing process followed up for suture 
removal appointment.
RESULTS: Statistically significant p ≤ 0.05 decreases in healing period when we compare patients treated with 
topical HA gel and those without topical HA gel.
CONCLUSION: The use of topical HA gel may have advantages for soft-tissue healing and decrease healing period 
for patients has OAF treated with surgical buccal flap.
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Introduction
Oroantral fistula (OAF) is a connection 
between maxillary sinus and oral cavity started as 
opening result from maxillary posterior teeth extraction, 
dental infections, osteomyelitis, radiation therapy, or 
trauma [1], [2]. Failure of immediate management of 
that opening leads to pathological duct with epithelial 
lining and granulation tissue filling termed fistula [3].
The presence of OAF might cause inflammation 
of the maxillary sinus and infection due to oral bacteria 
and food debris escape from oral cavity that requires 
more treatment that is complicated [4].
Management of OAF depend on the size, 
chronicity, and degree of maxillary sinus involvement, 
generally different techniques available such as buccal 
or palatal flap, bone graft, platelet-rich fibrin (PRF) clot, 
and PRF membrane and others [5], [6], [7].
OAF closure by tissue flaps has wide area in 
clinical practice, especially in mild and moderate size 
fistula. Buccal flap widely used because of easy, quick, 
and low failure rate, however, buccal flap associated 
with post-operative pain, swelling, and decrease of 
buccal sulcus, which trouble the use of prosthesis in 
the future [8], [9].
Hyaluronic acid (HA) is a polymer of glucuronic 
acid and N-acetylglucosamine disaccharide that 
found in many tissues such as eye, skin, joints, and 
other tissue. HA plays crucial role in connective tissue 
integrity and elasticity that favorite the use of it in various 
pharmaceutical preparations [10], [11].
The therapeutic advantages of HA proved in 
various surgical and non-surgical fields due its ability to 
promote healing, reduce infection in addition to induction 
of fibroblast proliferation and angiogenesis [12].
 In dental practice, HA used topically for the 
treatment of periodontitis twice daily for a month reduce 
inflammatory process and improve the state according 
to a study made by Mesa et al. [13].
Another study done by Koray et al. [14] found 
that applying 0.2% HA spray 3 times a day, for 7 days 
after a surgery for impacted third molar to the extraction 
area, reduce swelling and trismus throughout the post-
operative period.
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The aim of the current study was to evaluate 
the effect of HA gel topical application on pain, swelling, 
and healing period of OAF treated surgically by buccal 
flap.
Methods
This is a retrospective study conducted to 
evaluate the effect of topical HA gel on the healing of 
OAF treated by buccal flap compared with patients 
treated without HA gel application during the period 
from March to December 2018. The records of patients 
treated by one maxillofacial surgeon in AL-Hilla 
Teaching Hospital maxillofacial clinic evaluated 
retrospectively.
Patients
Twenty patients of both sexes included in study 
all of them have chronic OAF treated by surgical buccal 
flap. Ten of them received HA gel applied directly after 
suturing and instructed to apply twice daily until suture 
removal, while the other 10 patients were without HA 
gel (Table 1).
Healing evaluated during suture removal 
appointment by clinical examination.
Outcomes are as follows:
•	 Decrease rate of dehiscence and suture failure
•	 Decrease gingival inflammation
•	 Adverse reactions and infection
•	 Healing period.
Inclusion criteria
Traumatic tooth extraction with immediate 
opening more than 4 mm and patients with acute fistula 
more than 4 mm included in the study.
Exclusion criteria
The following criteria were excluded from the 
study:
•	 Patients with osteomyelitis
•	 Patients with tumors
•	 Patients with syphilis
•	 Patients with osteoradionecrosis
•	 Patients with mucormycosis.
Treatments
Buccal flap technique
All patients treated with Rehrmann [15] 
buccal advancement flap in which two divergent 
incisions made in the buccal side of the alveolus the 
horizontal release made to release the periosteum 
to allow advancement and closure of OAF without 
tension.
Post-operative treatments and instructions
All patients prescribed with antibiotics, 
analgesia, and nasal decongestant. Patients were 
instructed to wear surgical stent for 7-10 days and a 
date of suture removal was set at day 14. Patients were 
clinically examined at days 7, 10, and 14.
Instructions
Patients with HA gel advised to apply the gel 
twice daily for 14 days.
Patients of both groups instructed to stop 
smoking, avoid nose blowing and open mouth widely 
while sneezing.
Drugs
•	 HA gel 0.2%, GEGIGEL (Ricerfarma Gengigel 
Gingival Gel 20 ml, EU).
•	 Paracetamol 500 mg tablet, Panadol 
(GlaxoSmithKline, UK).
•	 Amoxicillin + clavulanic acid oral tablet 1000 mg 
(CoAmox Acino, Acino Pharma, Switzerland).
•	 Xylometazoline nasal decongestant.
Statistical analysis
The data evaluated at the level of significant 
of ≤0.05 by independent sample t-test and one-way 
ANOVA using IBM SPSS Statistics software 23.
Results
Evaluation of 20 patients had oroantral fistula 
treated with buccal flap show significant p ≤ 0.05 
decrease in healing period when we compare patients 
Table 1: Distribution of patients included in the study according to gender and area of OAF
Groups Numbers Male no. Female no. Area of oroantral fistula
1st molar no. 2nd molar no. 1st pre molar no. 2nd premolar no.
Patients treated with HA 10 4 6 2 2 2 4
Patients treated with HA 10 4 6 2 2 2 4
OAF: Oroantral fistula, HA: Hyaluronic acid.
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treated with topical HA gel (HA) and those without 
topical HA gel (Table 2).
Table 2: Differences in healing time between patients treated 
with HA and those treated without HA
Criteria Groups n Mean Std. 
deviation
Std. error 
mean
p-value
Healing time With HA 10 10.0000 1.49071 0.47140 0.000 ≤ 0.05*
Without HA 10 19.4000 1.50555 0.47610
*p ≤ 0.05. HA: Hyaluronic acid.
Patients of both group show no dehiscence or 
suture failure at surgical site when inspected at day 14 
(suture removal appointment) and neither of them show 
sign of infection too.
On the other hand, gingival enlargement 
decreased and about to be resolved completely in 
patients treated with topical HA gel than those without 
topical HA gel during clinical examination appointments 
at days 7 and 10 with complete healing observed at 
suture removal appointment (day 14).
No significant differences in healing period 
observed between male and female patients of both 
treatment groups p ≥ 0.05, Table 3.
Table 3: Differences in healing period between male and 
female of both treatment groups
Criteria Gender n Mean Std. 
deviation
Std. error 
mean
p-value
Healing time Female 12 14.7500 4.86406 1.40413 0.958 ≥ 0.05
Male 8 14.6250 5.62996 1.99049
No adverse drug reactions recorded to drugs 
prescribed for both groups.
Discussion
Oroantral communications and fistulas are 
complications often faced by oral and maxillofacial 
surgeons commonly after maxillary molars and 
premolars extraction due to their roots proximity with 
maxillary sinus [16].
In the following study, patients were suffer 
from OAF and treated with buccal flap according to the 
decision of their maxillofacial surgeon. To decrease 
post-operative discomfort and healing period, HA 
gel applied and prescribed to the patients due to its 
known ability to facilitate wound healing and wound 
protection without reported contraindications or serious 
interactions [17].
The result of the current study shows significant 
decrease in healing period for patients treated with HA 
gel when compared with patients treated without it. The 
following result may due to the proved ability of HA in 
stimulation of fibroblast proliferation and collagen fiber 
deposition that decrease healing time and promote 
rapid wound closure, especially in late stage of wound 
healing [18].
This finding agrees with Lee et al. [19]. study 
that found reduction in healing period and ulcers number 
when they apply 0.2% HA gel twice daily for 2 weeks 
to patients have recurrent aphthous ulcerations and 
oral ulceration due to Behcet’s disease. Furthermore, 
Romeo et al. [20] showed that applying 1.33% HA and 
amino acids gel, topically 3 times a day for 1 week, can 
promote faster healing in patients who underwent an 
excisional biopsy of the oral soft tissues using laser 
than the control group. The previous study outcome 
similar to our study finding except that the gel applied 
in this study contains 0.2% HA and used twice a day.
In contrast with the previous studies finding 
and the current one, Galli et al. [21] conducted a 
study using a single application of 0.8% HA and found 
no improvement in healing when applied to different 
surgical site in the oral cavity. However, this may due 
to differences of incisional site size, as none of them is 
flap wound in addition to the frequency of gel application 
and concentration. Henceforth, well-documented 
clinical trials required to assess the efficiency of HA on 
reduction of healing period after surgical buccal flap 
closure of OAF.
No statistically significant differences between 
male and female observed in healing period for both 
treatment groups (Table 3). This finding comes with 
Rodanant et al. [22] who found no significant variation 
among male and female in healing outcome after 7 days 
of surgical wound closure. This finding accepted in regard 
of no anatomical or physiological differences between 
male and female in healing process postoperatively.
The limitation of this study was small sample 
size due to decision to review the records of patients 
treated by the same operator rather than multicenter 
study. We recommend doing multicenter evaluation for 
different type of oral surgical operation to assume the 
effect of 0.2% HA gel on healing.
Conclusion
According to the present study finding, we 
conclude that topical application of 0.2% HA gel to a 
surgical closure of OAF treated surgically by buccal flap 
reduce healing period without recorded adverse effect.
Ethical Approval
All procedures performed in studies involving 
human participants were in accordance with the ethical 
standards of the institutional board and with the 1964 
Helsinki Declaration and its later improvements.
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